Catalyst Pharmaceuticals
CPRX
#3627
Rank
A$5.59 B
Marketcap
A$45.69
Share price
0.00%
Change (1 day)
46.31%
Change (1 year)

Catalyst Pharmaceuticals (CPRX) - Total assets

Total assets on the balance sheet as of March 2026 : A$1.66 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's total assets are A$1.66 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Catalyst Pharmaceuticals - Total assets on balance sheet (from 2004 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$0.69 B25.01%
2022-12-31A$0.55 B68.29%
2021-12-31A$0.32 B31.11%
2020-12-31A$0.25 B55.86%
2019-12-31A$0.16 B87.05%
2018-12-31A$85.8 M-21.54%
2017-12-31A$0.10 B89.03%
2016-12-31A$57.85 M-29.87%
2015-12-31A$82.5 M53.77%
2014-12-31A$53.65 M88.64%
2013-12-31A$28.44 M76.05%
2012-12-31A$16.15 M165.08%
2011-12-31A$6.09 M6.16%
2010-12-31A$5.74 M-35.26%
2009-12-31A$8.86 M-48%
2008-12-31A$17.05 M-10.6%
2007-12-31A$19.07 M-27.06%
2006-12-31A$26.15 M2324.35%
2005-12-31A$1.07 M350.4%
2004-12-31A$0.23 M
2002-12-31A$0.19 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$286.42 B 17,103.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$291.80 B 17,426.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$160.21 B 9,522.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$4.62 B 177.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$0.11 B-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$17.00 B 921.55%๐Ÿ‡บ๐Ÿ‡ธ USA